Even people who achieve the treatment goals with the new obesity pharmacotherapies might decide to undergo bariatric surgery to support long-term weight maintenance because either they experience weight regain on the medication or they do not have long-term access to obesity pharmacotherapy, or they prefer not to take obesity pharmacotherapy lifelong
Other side effects, though may get a lot of media attention, are doubtful based on the current evidence from thousands of patients in clinical trials
If you think of all the possible mechanisms, across GLP-1, GIP, amylin, and even cannabinoid receptors, you get a giant Venn diagram of overlapping options
Advances in Universal CAR-T Cell Therapy
Both agents affect appetite signaling and metabolic pathways, raising concerns about additive effects and unpredictable outcomes